Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-22-026683
Filing Date
2022-10-19
Accepted
2022-10-19 20:06:19
Documents
2
Period of Report
2022-10-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_166622435879164.html 3  
1 FORM 3 wf-form3_166622435879164.xml 3 3597
2 MEREDETH GOLDWASSER - POA ex-24.htm EX-24 4580
  Complete submission text file 0001628280-22-026683.txt   9520
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address PRIME MEDICINE, INC. 21 ERIE ST. CAMBRIDGE MA 02139
Business Address
Goldwasser Meredith (Reporting) CIK: 0001922606 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41536 | Film No.: 221319560